Cargando…

Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma

Previous studies demonstrated that the loss of function of the CDKN2A/p16/INK4A gene is mainly caused by the hypermethylation of CDKN2A, however, whether or not it is associated with the incidence and clinicopathological characteristics of endometrial carcinoma (EC) remains unclear. In this study, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Li, Wang, Hanwei, Miao, Jingwei, Liang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642515/ https://www.ncbi.nlm.nih.gov/pubmed/26283007 http://dx.doi.org/10.1038/srep13238

Ejemplares similares

Detection and significance of human papillomavirus, CDKN2A (p16) and CDKN1A (p21) expression in squamous cell carcinoma of the larynx
por: Chernock, Rebecca D., et al.
Publicado: (2012)

Stromal p16 expression is significantly increased in endometrial carcinoma
por: Yoon, Gun, et al.
Publicado: (2016)

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer
por: Tang, Bo, et al.
Publicado: (2015)

Clinicopathological significance and potential drug target of RUNX3 in breast cancer
por: Yu, Ying-Ying, et al.
Publicado: (2014)

Clinicopathological significance and potential drug target of T-cadherin in NSCLC
por: Wang, Zhidong, et al.
Publicado: (2014)

Expression of mitochondrial transcription factor A in endometrial carcinomas: clinicopathologic correlations and prognostic significance
por: Toki, Naoyuki, et al.
Publicado: (2010)

The Clinicopathological Significance and Prognostic Value of Androgen Receptor in Endometrial Carcinoma: A Meta-Analysis
por: Wu, Xirong, et al.
Publicado: (2022)

Clinicopathological significance and potential drug target of p15(INK4B) in multiple myeloma
por: Li, Jun, et al.
Publicado: (2014)

p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances
por: Geyer, Lucas, et al.
Publicado: (2023)

Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma
por: Csepregi, Antal, et al.
Publicado: (2010)

Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance
por: Yang, Mei, et al.
Publicado: (2022)

Clinicopathological significance of claudin-4 in gastric carcinoma
por: Zhu, Jin-Liang, et al.
Publicado: (2013)

Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.
por: Schmidt, E. E., et al.
Publicado: (1997)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Transcriptional regulation of CDKN2A/p16 by sirtuin 7 in senescence
por: Rodríguez, Sergio, et al.
Publicado: (2022)

Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance
por: Wang, Shu, et al.
Publicado: (2021)

DIPG-33. P16 IMMUNOHISTOCHEMICAL EXPRESSION AS A SURROGATE ASSESSMENT OF CDKN2A ALTERATION IN GLIOMAS LEADING TO PROGNOSTIC SIGNIFICANCES
por: Geyer, Lucas, et al.
Publicado: (2023)

Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma
por: Liang, Chaojie, et al.
Publicado: (2018)

The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review
por: Su, Yunshu, et al.
Publicado: (2015)

Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis
por: Bai, Yi-Yang, et al.
Publicado: (2019)

Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
por: Cottone, Lucia, et al.
Publicado: (2020)

Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort
por: Ibrahim, Isaura S., et al.
Publicado: (2023)

Clinicopathological roles of adiponectin and leptin receptors in endometrial carcinoma
por: YABUSHITA, HIROMITSU, et al.
Publicado: (2014)

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
por: Zhu, Qing, et al.
Publicado: (2022)

Clinicopathological significance of the p16 hypermethylation in multiple myeloma, a systematic review and meta-analysis
por: Yu, Huiqing, et al.
Publicado: (2017)

Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma
por: Ruz-Caracuel, Ignacio, et al.
Publicado: (2021)

CDKN2a/p16 Antagonizes Hepatic Stellate Cell Activation and Liver Fibrosis by Modulating ROS Levels
por: Lv, Fangqiao, et al.
Publicado: (2020)

Preoperative magnetic resonance imaging predicts clinicopathological parameters and stages of endometrial carcinomas
por: Wu, Chia‐Ying, et al.
Publicado: (2021)

P16 Expression in Human Breast Carcinoma and its Relationship to Clinicopathological Parameters
por: Mohammadizadeh, Fereshteh, et al.
Publicado: (2023)

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma
por: Dai, Wei, et al.
Publicado: (2016)

Retracted: SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Downregulation of miR-136-5p in hepatocellular carcinoma and its clinicopathological significance
por: Ding, Hua, et al.
Publicado: (2017)

Expression of matrix metalloproteinase-2 and survivin in endometrioid and nonendometrioid endometrial cancers and clinicopathologic significance
por: Yilmaz, Evren, et al.
Publicado: (2011)

Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
por: Xu, Lijun, et al.
Publicado: (2015)

A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma
por: Liang, Hai-wei, et al.
Publicado: (2017)

The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers
por: Choi, Yoon Sung, et al.
Publicado: (2015)

Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.
por: Niwa, K., et al.
Publicado: (1994)

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.
por: Berns, E. M., et al.
Publicado: (1995)

FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma
por: Chung, Catherine T-S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_06mi404egvc3a8j67eef6pfclg